Guangdong Yuanning Pharmaceutical Co., Ltd.

Preliminary study: Main purpose: This study used Cefpodoxime Proxetil Tablets (Specification: 0.1g/tablet, Dose: 0.1g) produced by Kangzhi Pharmaceutical Co., Ltd. as the test preparation, and Cefpodoxime Proxetil Tablets (Trade name: BANAN®, Specification 0.1g/tablet, Dose 0.1g) produced by Daiichi Sankyo Co., Ltd. as the reference preparation to investigate the pharmacokinetic parameters and intra-individual coefficient of variation of the test preparation and reference preparation in healthy subjects under fasting and postprandial conditions, and to verify the rationality of the blood drug concentration analysis method, blood collection time, washout period time interval and other settings. Secondary purpose: Observe the safety of the test preparation and reference preparation in healthy subjects. Formal trial: Main purpose: This study uses Cefpodoxime Proxetil Tablets (specification: 0.1g/tablet, dose: 0.1g) produced by Kangzhi Pharmaceutical Co., Ltd. as the test preparation and Cefpodoxime Proxetil Tablets (trade name: BANAN®, specification 0.1g/tablet, dose 0.1g) produced by Daiichi Sankyo Co., Ltd. as the reference preparation to evaluate the bioequivalence of the test preparation and the reference preparation when administered in the fasting and fed state. Secondary purpose: To observe the safety of the test preparation and the reference preparation in healthy subjects.